Scientists are testing whether GLP-1 drugs can help to cut cravings for cigarettes, alcohol and opioids — as well as food.

The weight loss medications can be part of a long-term treatment strategy for adults, according to new World Health ...

TUESDAY, Dec. 2, 2025 (HealthDay News) — The World Health Organization (WHO) released its first-ever guideline on using GLP-1 ...

The Zepbound price cut is the latest move in a price war with Denmark’s Novo Nordisk, which is making it significantly less ...

Wegovy maker Novo Nordisk is planning to test its experimental obesity drug, CagriSema, in overweight children and ...

The World Health Organization is now recommending GLP-1 drugs as a tool to manage obesity in adults. The guidance, which says ...

Novo Nordisk submitted a higher-dose version of semaglutide (Wegovy) to the FDA for approval as a weight-management treatment ...

The World Health Organization is now recommending GLP-1 drugs for adults trying to manage obesity. Dr. Natalie Azar explains ...

Dec. 1, 2025 Get more news © 2025 NBCUniversal Media, LLC ...

Marketers are positioning weight-loss shots as cosmetic elixirs for anyone who wants to lose a few pounds. Doctors warn that ...

The WHO issues its first official guidance on GLP-1 drugs for obesity treatment, as the disease affects over one billion ...